The epidemic evidences of worldwide rapid rise in prevalence of obesity and diabetes have focused efforts on development of intervention strategies which both sensitize insulin action and produce sustained improvements in β cell function (Rhodes, 2005). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.